Evidence map›Paper›PMID 36798248›Full record

ArticleResearch square2023

Variational Temporal Deconfounder for Individualized Treatment Effect Estimation with Longitudinal Observational Data.

Zheng Feng, Mattia Prosperi, Yi Guo, Jiang Bian

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zheng FengUniversity of Florida.
Mattia ProsperiUniversity of Florida.
Yi GuoUniversity of Florida.
Jiang BianUniversity of Florida.
University of Florida · US

Funding

PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System DiseasesU01TR003709 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI BIAN, JIANG, CHEN, YONG · 2022 to 2025
$4.7M
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical KnowledgeR01AG076234 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Jiang Bian, Fei Wang · 2022 to 2026
$3.8M
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)R01AI170187 · NIAID · UNIVERSITY OF FLORIDA · PI MARIA LUISA ALCAIDE, Deborah Lynne Jones · 2022 to 2026
$3.7M
Forecasting trajectories of HIV transmission networks with a novel phylodynamic and deep learning frameworkR01AI145552 · NIAID · UNIVERSITY OF FLORIDA · PI Simone Marini, Mattia Prosperi · 2020 to 2026
$3.6M
Developing Computational Methods for Surveillance of Antimicrobial Resistant AgentsR01AI141810 · NIAID · UNIVERSITY OF FLORIDA · PI BOUCHER, CHRISTINA, PROSPERI, MATTIA · 2019 to 2023
$2.1M
The benefits and harms of lung cancer screening in FloridaR01CA246418 · NCI · UNIVERSITY OF FLORIDA · PI BIAN, JIANG, GUO, YI · 2020 to 2023
$1.7M
Optimizing the Population Representativeness of Older Adults in Alzheimer's Disease and Related Dementia Clinical TrialsR21AG068717 · NIA · UNIVERSITY OF FLORIDA · PI BIAN, JIANG, GUO, YI · 2020 to 2021
$419k
Optimizing the Population Representativeness of Older Adults in Cancer TrialsR21CA253394 · NCI · UNIVERSITY OF FLORIDA · PI BIAN, JIANG, GUO, YI · 2021 to 2021
$392k
NCATS NIH HHS U01 TR003709NCI NIH HHS R01 CA246418NCI NIH HHS R21 CA253394NIAID NIH HHS R01 AI141810NIAID NIH HHS R01 AI145552NIAID NIH HHS R01 AI170187NIA NIH HHS R01 AG076234NIA NIH HHS R21 AG068717
6 · The paper itself

Abstract

Purpose: This paper proposes a new approach, Variational Temporal Deconfounder (VTD), for estimating individualized treatment effects (ITE) from longitudinal observational data, where we address the hidden confounding issues by using proxies (i.e., surrogate variables that serve for unobservable variables). Methods: We build VTD by incorporating a variational recurrent autoencoder that learns the latent encodings of hidden confounders from observed proxies and an ITE estimation network that takes the learned hidden encodings to predict the probability of receiving treatments and potential outcomes. Results: We test VTD on both synthetic and real-world clinical data, and the results from synthetic data experiments demonstrate VTD's effectiveness in deconfounding by outperforming existing methods, while results from two real-world datasets (i.e., Medical Information Mart for Intensive Care version III [MIMIC-III] and the National Alzheimer's Coordinating Center [NACC] database) suggest that the performance of the VTD model outperforms existing baseline models, however, varies depending on the assumptions of underlying causal structures and availability of proxies for hidden confounders. Conclusion: The VTD offers a unique solution to address the confounding bias without the "unconfoundedness" assumption when estimating the ITE from longitudinal observational data. The elimination of the requirement for the "unconfoundedness" assumption makes the VTD more versatile and practical in real-world clinical applications of personalized medicine.

Indexed as

Causal inferenceIndividualized treatment effectsInterpretable AIObservational data

Identifiers

PMID36798248
PMCPMC9934764
OpenAlexW4319312618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.